Table.

Clinical Characteristics of Reported Cases of MOG Antibody-associagted Disease after SARS-CoV-2 Infection.

Case No	Reference	Patient age/gender	Time duration from COVID-19 to onset of neuroligal symptoms	CNS lesions	CSF findings	Treatment	Clinical outcome
1	16	47/M	No symptoms of infection	Bilateral optic neuritis	CSF normal cell cout and chemistry, RT-PCR negative for SARS-CoV-2	IVMP, oral steroid	Recoverd
2	17	11/M	2 weeks	Bilateral optic neuritis	CSF WBC 55 cells/μL, noraml protein OCB absent	IVMP, oral steroid	Recoverd
3	18	44/M	2 weeks	Bilateral optic neuritis	CSF WBC 3 cells/μL, protein 50 mg/dL, OCB absent	IVMP, oral steroid	Recoverd
4	2	26/M	2 days	Bilateral optic neuritis, myelitis	CSF WBC 55 cells/μL, protein 31 mg/dL, OCB present RT-PCR negative for SARS-CoV-2	IVMP, oral steroid	Recoverd
5	19	44/F	1 weeks	CNS inflammatory vasculopathy	CSF WBC 13 cells/μL, protein 507 mg/L, RT-PCR negative for SARS-CoV-2	IVMP, oral steroid, PE	Recoverd
6	Current case	24/F	3 weeks	Unilataral optic neuritis, myelitis, CNS demyelinatining lesions	CSF WBC 16 cells/μL, protein 51 mg/dL, OCB present RT-PCR negative for SARS-CoV-2	IVMP, oral steroid	Recoverd

CNS: central nervous system, WBC: white blood count, OCB: oligoclonal band, IVMP: intravenous methylprednisolone, PE: plasma exchange